ES469749A1 - Nitroimidazole composition - Google Patents

Nitroimidazole composition

Info

Publication number
ES469749A1
ES469749A1 ES469749A ES469749A ES469749A1 ES 469749 A1 ES469749 A1 ES 469749A1 ES 469749 A ES469749 A ES 469749A ES 469749 A ES469749 A ES 469749A ES 469749 A1 ES469749 A1 ES 469749A1
Authority
ES
Spain
Prior art keywords
nitroimidazole
composition
mono
nitroimidazole drug
lyophilize
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES469749A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp
Original Assignee
Pfizer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp filed Critical Pfizer Corp
Publication of ES469749A1 publication Critical patent/ES469749A1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

A process for the preparation of a pharmaceutical formulation of a nitroimidazole drug consisting of treating the nitroimidazole drug with an aqueous solution of a pharmaceutically acceptable salt of a mono- or di-hydroxybenzoic acid or of a mono- or di-hydroxybenzyl alcohol, sterilize and, if desired, lyophilize the resulting solution. (Machine-translation by Google Translate, not legally binding)
ES469749A 1977-05-14 1978-05-11 Nitroimidazole composition Expired ES469749A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2037977 1977-05-14

Publications (1)

Publication Number Publication Date
ES469749A1 true ES469749A1 (en) 1978-12-16

Family

ID=10144988

Family Applications (1)

Application Number Title Priority Date Filing Date
ES469749A Expired ES469749A1 (en) 1977-05-14 1978-05-11 Nitroimidazole composition

Country Status (16)

Country Link
JP (1) JPS542315A (en)
AU (1) AU504551B1 (en)
BE (1) BE867040A (en)
DE (1) DE2820992A1 (en)
DK (1) DK212678A (en)
ES (1) ES469749A1 (en)
FI (1) FI781507A (en)
FR (1) FR2390162A1 (en)
IL (1) IL54687A0 (en)
IT (1) IT1115599B (en)
LU (1) LU79655A1 (en)
NL (1) NL7805158A (en)
NO (1) NO781688L (en)
PT (1) PT68034B (en)
SE (1) SE7805471L (en)
ZA (1) ZA782736B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3070778D1 (en) * 1979-08-11 1985-07-25 Bayer Ag Antimycotic agents with enhanced release of the active ingredients
FR2624736B1 (en) * 1987-12-16 1991-03-22 Dietlin Francois NEW WATER-DISPERSIBLE PHARMACEUTICAL COMPOSITIONS BASED ON ORNIDAZOLE
CN104127379A (en) * 2014-08-14 2014-11-05 珠海亿邦制药股份有限公司 Ornidazole injection and preparation method thereof
CN110538144A (en) * 2019-06-13 2019-12-06 南京瓦尔生物医药有限公司 Ornidazole injection and S-ornidazole injection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4032645A (en) * 1975-06-19 1977-06-28 G. D. Searle & Co. Injectable metronidazole composition

Also Published As

Publication number Publication date
IT1115599B (en) 1986-02-03
BE867040A (en) 1978-11-13
SE7805471L (en) 1978-11-15
FI781507A (en) 1978-11-15
ZA782736B (en) 1979-05-30
NL7805158A (en) 1978-11-16
IT7823351A0 (en) 1978-05-12
DE2820992A1 (en) 1978-12-07
FR2390162A1 (en) 1978-12-08
NO781688L (en) 1978-11-15
JPS542315A (en) 1979-01-09
LU79655A1 (en) 1979-12-06
DK212678A (en) 1978-11-15
IL54687A0 (en) 1978-07-31
PT68034B (en) 1979-10-24
PT68034A (en) 1978-06-01
AU504551B1 (en) 1979-10-18

Similar Documents

Publication Publication Date Title
PT97689A (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS INCORPORATING AS ACTIVE INGREDIENT ISOXAZOL-4-CARBOXYLAMIDE AND HYDROXYLYLIDENE-CYANOOCETAMIDE
SE8402549D0 (en) SUBSTITUTED MORANOLINE DERIVATIVES
ES485062A1 (en) A procedure for preparing acetic acid derivatives (Machine-translation by Google Translate, not legally binding)
SE7902742L (en) DISUBSTITUTED 3-CEFEM-4-CARBOXYLIC ACID DERIVATIVES AND PROCEDURES FOR THE PREPARATION
IT7922743A0 (en) CONTROLLED EMISSION PHARMACEUTICAL DOSAGE COMPONENT.
ES410825A1 (en) Quinoline derivatives
ES469749A1 (en) Nitroimidazole composition
IE44339L (en) Piperazine derivatives.
GB2000025A (en) Nitroimidazole formulations
GB2021409A (en) Pharmaceutical composition
ES8102148A1 (en) 3-0-( beta -D-Glucuronopyranosyl)-soyasapogenol B
HU172372B (en) Insecticide compositions containing oxy-pyridine derivatives substituted with n,n-dialkylamino-ureic acid ester,and process for producing the active agent
DE2963010D1 (en) 3-chloro-6-hydroxy-5-methylbenzoic acid derivatives, corresponding pharmaceutical preparations, growth promoting compositions, the use of the compounds for promoting growth in certain animals and their manufacture
FR2392668A1 (en) COPROPORPHYRINE-BASED MEDICINAL PRODUCT
IT7823102A0 (en) DERIVATIVES OF AZOLYL-ALKAN-CARBOXYLIC ACIDS, PROCEDURE FOR THEIR PREPARATION AND THEIR USE AS FUNGICIDES.
IE35032B1 (en) Phenyl-azolyl-fatty acid derivatives,process for their production and their use as medicines
NL7509032A (en) PROCESS FOR PREPARING SUBSTITUTED 2H-PYRANE-2,6 (3H) -DION DERIVATIVES, AND OF PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT.
BE881317R (en) TAURINE DERIVATIVES WITH ANTILIPEMIC AND CHOLERETIC ACTIVITY, PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS AS AN ACTIVE COMPONENT
ES416766A1 (en) A procedure for the preparation of (3-trifluormethylphenoxy) - (4-chlorophenyl) acetate of 2-acetamidoetilo. (Machine-translation by Google Translate, not legally binding)
NO820180L (en) BASIC SUBSTITUTED ANTHRANIC ACIDS, PROCEDURES FOR THEIR PREPARATION AND THEIR USE
ES440208A1 (en) Piperazine compounds
NL174522C (en) METHOD FOR PREPARING HERBICIDE PREPARATIONS, AND FOR PREPARING THIOPROPIONIC ACID DERIVATIVES THEREIN AS ACTIVE INGREDIENTS.
ES455692A1 (en) Alkylenedioxy piperazine derivatives
JPS5251362A (en) Preparation of optically active pyrrolidine derivatives
GB1128372A (en) Injectable pharmaceutical compositions